James Vannice

Title: The Innovations of James Vannice

Introduction

James Vannice is an accomplished inventor based in Boulder, CO (US). He is known for his significant contributions to the field of biotechnology, particularly in the development of tumor necrosis factor (TNF) inhibitors. His work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

James Vannice holds a patent for a "Tumor necrosis factor (TNF) inhibitor and method for obtaining the same." This patent discloses at least two substantially purified TNF inhibitors, which are glycoproteins active against TNF. The isolation of 30 kDa and 40 kDa TNF inhibitors from urine is detailed in the patent. The deglycosylated forms of these inhibitors are described as being active against TNF. Notably, the 40 kDa TNF inhibitor is effective against both TNF alpha and TNF beta. The patent also includes the amino acid sequences of the 30 kDa and 40 kDa TNF inhibitors, along with methods for isolating these inhibitors from human U937 cell medium and producing the proteins using recombinant-DNA methods. James Vannice has 1 patent to his name.

Career Highlights

James Vannice has made significant strides in his career, particularly through his work at Amgen Inc. His research focuses on innovative solutions in biotechnology, contributing to advancements in medical treatments.

Collaborations

Throughout his career, James has collaborated with notable colleagues, including Michael T Brewer and Karin K Hale. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

James Vannice is a prominent inventor whose work on TNF inhibitors showcases his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in therapeutic strategies for various diseases.